DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Serine/Threonine-Specific Protein Kinase Inhibitors -Pipeline Insights, 2016" report to their offering.
Serine/Threonine-Specific Protein Kinase Inhibitors-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Serine/Threonine-Specific Protein Kinase Inhibitors. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Serine/Threonine-Specific Protein Kinase Inhibitors.
The report also assesses the Serine/Threonine-Specific Protein Kinase Inhibitors therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
- The report provides competitive pipeline landscape of Serine/Threonine-Specific Protein Kinase Inhibitors
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Serine/Threonine-Specific Protein Kinase Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Serine/Threonine-Specific Protein Kinase Inhibitors and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Overview
- Pipeline Therapeutics
- Therapeutics under Development by Companies
- Filed and Phase III Products
- Comparative Analysis
- Phase II Products
- Comparative Analysis
- Phase I and IND Filed Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Discontinued Products
- Dormant Products
- Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/b5n54m/serinethreonines